Decentralized Clinical Trials Promised Faster Recruitment. The Evidence on Actual Performance Is In.
Dr. Dereck Mush, MD, MBA
Curebase
Delivers software and clinical services to power decentralized and hybrid clinical trials.
What they do
Curebase offers a decentralised clinical trial platform combined with virtual site services. Their software enables researchers to conduct studies at any clinic or patient home, offering tools for remote consent, electronic data capture, and virtual investigator visits.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Decentralised trials
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- San Francisco, USA
- Region
- North America
- Founded
- 2017
- Total funding
- $40M raised
Notable investors: GGV Capital, Bold Capital Partners, Y Combinator, General Catalyst.
Also in Clinical Trials
Related on The Signal
Dr. Dereck Mush, MD, MBA
Pig Kidney Transplants Are Now in Human Trials. Here Is What EXPAND and Its Rivals Actually Have to Prove
Dr. Dereck Mush, MD, MBA
Inside SURPASS: ARPA-H's Bid to Redesign Clinical Trials
Dr. Dereck Mush, MD, MBA
Unlocking Orphan Neuromuscular Indications: Why IntraBio's Aqneursa Approval Signals a Regulatory Re-evaluation of Small-Cohort Crossover Trials
Dr. Dereck Mush, MD, MBA